The Vistria Group and Excellere Partners have bought SCA Pharmaceuticals LLC, an FDA-registered outsourcing facility.
SCA Pharma serves over 1,200 hospitals and health systems in the U.S. The company provides compounded drugs that are otherwise not commercially available. SCA Pharma was previously a portfolio company of Enhanced Healthcare Partners, a healthcare private equity firm.
“As exemplified during today’s public health crisis, SCA Pharma plays a mission-critical role in the healthcare ecosystem by providing hospitals with a reliable source of safe, ready-to-use product,” said Jon Maschmeyer, partner at Vistria.
The leadership team will remain with SCA and Milton Boyer will continue to serve in his current capacity as CEO. No changes are planned for the company’s daily operations.
William Blair & Company served as exclusive financial advisor and McDermott Will & Emery LLP served as legal counsel to SCA. Ropes & Gray LLP served as legal counsel to the buyers.